Lecture: Screening for Diabetes: When is it meaningful and how should it be performed

Media formats available:

Benefits of GLP-1RA and SGLT2-i in primary and secondary prevention of CVD in T2DM
Benefits of GLP-1RA and SGLT2-i in primary and secondary prevention of CVD in T2DM
CDMC 2018: Shifting gears in the management of diabetes and CVD
Benefits of GLP-1RA and SGLT2-i in primary and secondary prevention of CVD in T2DM
- Prof. Eduard Montanya, MD
Lecture: Managing diabetes in daily cardiovascular practice: Potential barriers and solutions
Lecture: Managing diabetes in daily cardiovascular practice: Potential barriers and solutions
CDMC 2018: Shifting gears in the management of diabetes and CVD
Lecture: Managing diabetes in daily cardiovascular practice: Potential barriers and solutions
- Prof. Richard Hobbs, MD
Lecture: The clinical landscape for T2DM and CVD: impact on guidelines and practice
Lecture: The clinical landscape for T2DM and CVD: impact on guidelines and practice
CDMC 2018: Shifting gears in the management of diabetes and CVD
Lecture: The clinical landscape for T2DM and CVD: impact on guidelines and practice
- Prof John E Deanfield
Lecture: Translating mechanisms to benefits: How can we explain the cardiovascular benefits of new diabetes drugs?
Lecture: Translating mechanisms to benefits: How can we explain the cardiovascular benefits of new diabetes drugs?
CDMC 2018: Shifting gears in the management of diabetes and CVD
Lecture: Translating mechanisms to benefits: How can we explain the cardiovascular benefits of new diabetes drugs?

PACE-CME